文献速递介入泌尿生殖外周血管DSA

凝血功能正常条件下医源性肾出血的血栓栓塞术联合或不联合N-丁基-2-氰基丙烯酸酯的应用研究

Transcatheter arterial embolization with N-butyl-2 cyanoacrylate or not for iatrogenic renal haemorrhage under normal coagulation condition.
PubMed 文献 · Br J Radiol · 2025-01-01

研究纳入49例凝血功能正常的医源性肾出血患者,分为NBCA组(12例)和非NBCA组(37例),比较经导管动脉栓塞术的疗效与安全性。非NBCA组血管造影阴性表现更常见(43.2% vs 0,P=0.012)。结论认为TAE对凝血功能正常IRH患者安全有效,无论是否使用NBCA胶。

要点

  • 凝血功能正常的医源性肾出血患者行TAE技术成功率高,两组均全部成功。
  • 非NBCA组血管造影阴性表现占43.2%,显著高于NBCA组的0(P=0.012)。
  • 两组原发及继发临床成功率、手术时间、费用均无统计学显著差异。

核心结论

  • TAE对凝血功能正常的医源性肾出血患者是安全有效的治疗方法,无论是否使用NBCA胶。

研究设计与样本

  • 研究纳入49例凝血功能正常的医源性肾出血患者,分为NBCA组(n=12)和非NBCA组(n=37),比较两组经导管动脉栓塞术的疗效与安全性。

关键影像表现/征象

  • 非NBCA组血管造影阴性表现较NBCA组更常见(43.2% vs 0,P=0.012)。
  • 两组治疗前后血清肌酐和尿素水平均无显著差异(P>0.05)。
  • TAE术后观察到轻微并发症,NBCA组比例高于非NBCA组(P=0.088)。

诊断标准与关键数值

  • 技术成功率:所有患者均达到技术成功。
  • 原发临床成功率:NBCA组与非NBCA组比较P>0.99;继发临床成功率两组比较P>0.99。
  • 手术时间两组比较P=0.469;手术费用两组比较P=0.057。

临床应用与阅片要点

  • 对于凝血功能正常的医源性肾出血患者,TAE是可选择的栓塞治疗方式,是否使用NBCA胶不影响技术成功和临床成功率。
  • 非NBCA组中血管造影阴性表现比例较高(43.2%),阅片时需注意造影阴性结果并不排除需栓塞治疗的出血来源。
  • NBCA组轻微并发症比例较高(P=0.088),术后应关注相关并发症表现。

局限性

  • 原文结论指出这些发现需要在大规模随机对照试验中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the effectiveness and safety of transcatheter arterial embolization (TAE) with N-butyl-2 cyanoacrylate (NBCA) versus without NBCA for the treatment of iatrogenic renal haemorrhage (IRH) in patients with normal coagulation profiles.

METHODS: Forty-nine participants with normal coagulation profiles were divided into 2 groups: NBCA (n = 12) and non-NBCA (n = 37). The primary outcome assessed was the primary clinical success rate, with secondary analyses conducted on technical success rate, secondary clinical success rate, procedure duration and cost, angiographic results, and adverse events.

RESULTS: Patients exhibited a near-normal coagulation condition (98.4%, 50/51). Technical success was attained in all patients, with no statistically significant differences observed between primary clinical success rate (P > .99), secondary clinical success rate (P > .99), procedure time (P = .469), and surgical costs (P = .057) when comparing the sides. In the non-NBCA group, negative angiographic findings were more prevalent compared with the NBCA group (43.2% vs 0, P = .012). No significant differences were found in serum creatinine and urea levels before and after treatment in both the groups (P > .05). Minor complications were observed after the TAE procedure, with a higher percentage in the NBCA group compared with the non-NBCA group (P = .088).

CONCLUSIONS: TAE has been shown to be a safe and effective treatment for IRH in patients with normal coagulation conditions, regardless of the use of NBCA glue.

ADVANCES IN KNOWLEDGE: There were no significant differences in procedure time or costs between the NBCA group and other treatment modalities. However, these findings require validation in large-scale randomized controlled trials.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Wan Y, Liu Y, Li D, et al. Transcatheter arterial embolization with N-butyl-2 cyanoacrylate or not for iatrogenic renal haemorrhage under normal coagulation condition. Br J Radiol. 2025. PMID: 40700592. doi:10.1093/bjr/tqaf170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。